The 7 analysts offering 12-month price forecasts for Dyne Therapeutics Inc have a median target of 29.00, with a high estimate of 36.00 and a low estimate of 20.00. The median estimate represents a +153.94% increase from the last price of 11.42.
The current consensus among 7 polled investment analysts is to Buy stock in Dyne Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.80
Reporting Date Feb 29
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.